The biopharmaceutical company Biopharma Plasma (Kyiv) has opened a plasma center in Kolomyia (Ivano-Frankivsk Oblast), marking the company’s 23rd plasma center. The company announced this on LinkedIn.
“This new center is another step toward expanding access to plasma donation and strengthening our contribution to the production of life-saving medicines,” the company stated.
As previously reported, in June, Biopharma Plasma opened a plasma center in Zhytomyr, which became the company’s 22nd plasma center. Before the war, Biopharma Plasma planned to open approximately four to five new centers each year, investing about $2.5 million in each.
By the end of 2027, Biopharma plans to launch a plant in Oradea, Romania, with an initial investment of 85 million euros. In September of this year, the company plans to launch the first phase of its plant in Uzhhorod for the production of pharmaceutical products and immunobiological preparations, which will provide a full cycle of blood plasma processing. The company has already invested 67 million euros in the construction; the total cost of the first phase is 75 million euros. According to the plan, the volume of blood plasma-based drug production in Uzhhorod will be twice that of production in Bila Tserkva, amounting to up to 1.5 million liters of blood plasma per year, while the project in Romania will be twice as large.
Biopharma Plasma, Donation, Kolomyia, PHARMACEUTICALS, PLASMA
Related:
